James Healy, 10% Owner at Inozyme Pharma, Inc. (INZY), bought 2,028,308 shares at $16.00 ($7.0M) on 2020-07-28, disclosed to the SEC on 2020-07-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,590,808 | $0 | 0.0% |
| 2 | $16.00 | 437,500 | $7.0M | 100.0% |
| Total | $3.45 avg | 2,028,308 | $7.0M | 100% |
| Filing → |
| RAPP | BUY | 2024-06-10 | $9.5M | — | Filing → |
| AVBP | BUY | 2024-01-31 | $8.0M | — | Filing → |
| NTRA | SELL | 2023-12-22 | $37.8M | — | Filing → |